Newsroom

Hurotics, a company specializing in soft exosuits (wearable robots), announced that it has raised KRW 25 billion in a Series A round. The round was led by Atinum Investment, bringing the company's cumulative funding to more than KRW 33.5 billion. Most of its major existing investors, including Stonebridge Ventures, Mirae Asset Venture Investment, AJU IB Investment, Wonik Investment Partners and Doosan Investment, made follow-on investments. A number of new investors also joined, including strategic investors (SIs) from the healthcare, retail and IT sectors such as Daewoong, NAVER and Lotte, along with the Industrial Bank of Korea (IBK).

 

According to the company, the participation of strategic investors from healthcare, retail and IT reflects their interest in the potential to expand the business from hospital rehabilitation to everyday walking assistance and a wearable physical AI data platform. Hurotics plans to work with them on expanding hospital supply and distribution networks, entering overseas markets and advancing its data and software platform.

 

Hurotics is a soft exosuit company founded in July 2022 by Giuk Lee, a professor in the School of Mechanical Engineering at Chung-Ang University. Building on research into garment-type wearable robots conducted at Harvard University's Wyss Institute, the company develops robots that assist human movement and help restore and enhance physical ability.

 

Its flagship product, H-Medi, is a medical soft exosuit for gait rehabilitation that has received Class II combination medical device certification from Korea's Ministry of Food and Drug Safety (MFDS). Using cable-and-tendon actuation that mimics the way muscles contract, it is designed to be worn like clothing. Sensors analyze the wearer's gait in real time and supplement only as much force as needed, helping wearers walk using their own muscles.

 

Since its commercial launch in September 2025, H-Medi has been adopted by hospitals including Severance Hospital in Sinchon, Chung-Ang University Hospital and Korea University Hospital. In June, it was exported to the University of Illinois Chicago (UIC) in the United States, where it is used for stroke rehabilitation research and physical therapist education. While building evidence through clinical research with medical institutions, Hurotics is also pursuing commercialization in Japan and Southeast Asia.

 

Hurotics has built an organization that connects R&D, mass production and clinical application. About 45% of its roughly 47 employees hold master's or doctoral degrees, supporting its technological advancement. CMO Dongsoo Kim, a former rehabilitation medicine specialist at Severance Hospital, brings clinical needs into the product, while a team with large-corporation experience, led by CTO Seunghoon Han, a former executive at Samsung Electronics and Hyundai Motor Group, handles product development and mass production.

 

The new funding will go toward overseas regulatory approvals and distribution for H-Medi, as well as the development and mass production of H-Care, an everyday walking-assistance robot. Over the mid to long term, the company plans to develop software services based on movement data, such as personalized gait algorithms and prediction of sarcopenia and fall risk, and to expand into a wearable physical AI data platform.

 

"Our goal is for the recovery of movement that begins in the hospital to carry over into health in everyday life," said CEO Giuk Lee. "With this investment, we will accelerate the global expansion of H-Medi and the commercialization of H-Care, and combine them with physical AI to introduce wearable robots that look after people's health in daily life as well."

---

It is an exceptionally happy, joyful, proud and energizing day.

 

To everyone at Hurotics: let's run even harder with a fresh start!